Novel Technique Identified to Counter Antimicrobial Resistance

by François Dupont
5 comments
antibiotic resistance children

Scientists from the University of Oklahoma’s Center for Antibiotic Discovery and Resistance have isolated molecules capable of impeding bacterial efflux pumps, thereby bolstering the effectiveness of antibiotics. This innovative development, grounded in a “molecular wedge” methodology, presents a viable pathway for pioneering therapies aimed at combatting antibiotic resistance.

The World Health Organization has categorized antimicrobial resistance as a global issue, given the reduced efficacy of most contemporary clinical antibiotics against specific disease-causing bacteria. The Center for Antibiotic Discovery and Resistance at the University of Oklahoma is spearheaded by Dr. Helen Zgurskaya and Dr. Valentin Rybenkov, both of whom are committed to researching alternative therapeutic interventions.

Antibiotics function by interacting with distinct components of bacterial cells, such as the cell wall or DNA. Bacterial cells can gain resistance to antibiotics through various mechanisms, including the evolution of efflux pumps—proteins situated on the cell surface. These pumps expel antibiotics from the cell before they can interact with their intended targets, rendering the antibiotics ineffective.

Recent findings by researchers from the University of Oklahoma, however, have been documented in the academic journal Nature Communications. The study introduces a new category of molecules that obstruct the efflux pump, thereby restoring the antibiotic’s potency.

These pump inhibitors employ an innovative action mechanism, which was previously not well-understood. The team led by Dr. Zgurskaya, in collaboration with researchers from the Georgia Institute of Technology and King’s College London, has ascertained that these inhibitors function as a “molecular wedge.” This wedge specifically targets the interface between the inner and outer bacterial cell membranes, amplifying the antibiotics’ antibacterial activities. This newfound understanding could expedite the development of next-generation therapeutics for clinical use.

Dr. Zgurskaya has noted, “We are already in a post-antibiotic epoch, and the situation will exacerbate if fresh approaches are not identified to tackle antibiotic resistance in clinical settings. Our contributions in this field will aid the creation of new therapies, thereby potentially averting a looming crisis.”

Reference: “Conformational restriction shapes the inhibition of a multidrug efflux adaptor protein” authored by Benjamin Russell Lewis, Muhammad R. Uddin, Mohammad Moniruzzaman, Katie M. Kuo, Anna J. Higgins, Laila M. N. Shah, Frank Sobott, Jerry M. Parks, Dietmar Hammerschmid, James C. Gumbart, Helen I. Zgurskaya and Eamonn Reading, dated 18 July 2023, published in Nature Communications.
DOI: 10.1038/s41467-023-39615-x

Dr. Helen Zgurskaya serves as the George Lynn Cross Research Professor, and Dr. Valentin Rybenkov is a Professor of Biochemistry. Both are affiliated with the Department of Chemistry and Biochemistry in the Dodge Family College of Arts and Sciences at the University of Oklahoma. Further information about their work at the Center for Antibiotic Discovery and Resistance can be obtained from relevant sources.

Frequently Asked Questions (FAQs) about Antimicrobial Resistance

What is the main discovery made by the researchers at the University of Oklahoma’s Center for Antibiotic Discovery and Resistance?

The primary discovery is the identification of molecules that inhibit bacterial efflux pumps. These pumps are responsible for expelling antibiotics out of bacterial cells, making them ineffective. By inhibiting these pumps, the effectiveness of antibiotics is restored.

What does the “molecular wedge” mechanism refer to?

The “molecular wedge” mechanism refers to the novel way these inhibitory molecules work. They target the area between the inner and outer bacterial cell membranes and act as a wedge that prevents the efflux pump from expelling antibiotics, thereby enhancing their antibacterial activities.

Who are the key people involved in this research?

The research is led by Dr. Helen Zgurskaya and Dr. Valentin Rybenkov, both of whom are part of the University of Oklahoma’s Department of Chemistry and Biochemistry. The team also collaborated with scientists from the Georgia Institute of Technology and King’s College London.

How does this discovery potentially impact the global issue of antimicrobial resistance?

The discovery opens a new avenue for developing alternative therapeutic solutions to tackle the global challenge of antimicrobial resistance. As most clinical antibiotics have lost their efficacy against certain bacteria, this research provides a promising route for creating more effective treatments.

Where was this research published?

This research was published in the academic journal Nature Communications, with the paper titled “Conformational restriction shapes the inhibition of a multidrug efflux adaptor protein,” dated 18 July 2023.

What does Dr. Helen Zgurskaya say about the current state of antibiotic resistance?

Dr. Zgurskaya notes that we are already in a “post-antibiotic era” and warns that the situation will worsen unless new solutions are found to address antibiotic resistance in clinical settings. The research is aimed at facilitating the development of such new treatments.

How do antibiotics normally work and why do they become ineffective?

Antibiotics generally target specific components of bacterial cells, such as the cell wall or DNA, to kill or inhibit the bacteria. They become ineffective primarily because bacteria develop mechanisms like efflux pumps that remove the antibiotics from the cells before they can reach their targets.

More about Antimicrobial Resistance

You may also like

5 comments

Robert Lee October 7, 2023 - 1:39 am

If this works as they say, it could revolutionize medical treatment. But we also need to think bout side-effects and long term impact, not just the immediate benefits.

Reply
John Smith October 7, 2023 - 2:14 am

Wow, this is groundbreaking stuff. Its kinda scary to think we’re in a “post-antibiotic era,” but this research gives some hope. The molecular wedge thing is super interesting.

Reply
Sara Williams October 7, 2023 - 5:45 am

I’m amazed at how science keeps finding ways to fight back against antibiotic resistance. this could be a game changer, kudos to the team for their hard work.

Reply
Emily Clark October 7, 2023 - 11:23 am

Are they planning to take this to clinical trials anytime soon? The article mentions it could expedite next-gen therapeutics, but how long we talking here?

Reply
Mike Johnson October 7, 2023 - 2:00 pm

Incredible what these scientists are doin! We’ve heard about antibiotic resistance for years and it’s about time we found a way to combat it. Can’t wait to see where this research leads.

Reply

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.

SciTechPost is a web resource dedicated to providing up-to-date information on the fast-paced world of science and technology. Our mission is to make science and technology accessible to everyone through our platform, by bringing together experts, innovators, and academics to share their knowledge and experience.

Subscribe

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

© 2023 SciTechPost

en_USEnglish